Status
Conditions
About
A prospective cohort of relatively healthy individuals, using comprehensive clinical information, advanced imaging (including cardiac MRI), cardiovascular exercise physiology, metabolomics and genetic analysis. These findings will be correlated with adverse clinical outcomes including death, stroke and myocardial infarction. In selected cases, follow-up imaging and biomarker samples will also be obtained. These studies will enable us to begin to address a critical gap in our knowledge as to how best to interpret the very large amount of cardiovascular tests done in Singapore and how to better to predict outcomes and manage healthcare costs in our local populations
Full description
SingHEART sub-study will collect the following data types or perform the following investigations:
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Previous myocardial infarction (MI). This will include ST-elevation MI (STEMI) and non-ST-elevation MI (NSTEMI)
Known coronary artery disease - prior coronary revascularization
Known documented peripheral arterial disease
Previous stroke
a. Stroke is defined as new focal neurological deficit persisting more than 24hours21.
More than ongoing use of 2 or more anti-hypertensive agents
Prior history of cancer (excludes pre-cancerous lesions)
Expected life expectancy less than 1 year
Known definite diabetes mellitus or on treatment for diabetes mellitus
Known autoimmune disease or genetic disease
Known endocrine disease on treatment
Psychiatric illness
Asthma or chronic lung disease requiring long term medications or oxygen
Chronic infective disease, including tuberculosis, hepatitis B and C; and HIV
Inability to comply with study protocol
Any other acute or chronic medical or physical condition deemed by the investigator to affect study outcomes
Loading...
Central trial contact
Yuen Yet Lee, Nursing; Yeo Khung Keong, MBBS
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal